Atrás
Precio Adagene Inc (ADAG)
Gráfico del Precio de Acciones ADAG
ADAG Ganando
Adagene Inc
$1.96
2.08%
$0.04
Al cierre: Jan 16, 16:00:00 GMT-5
$1.98
1.24%
$0.02
Mercado Posterior: Jan 16, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$1.92
Precio de apertura
$1.88
Rango del día
$1.88 - $1.98
Rango de 52 semanas
$1.3 - $3.16
Volumen
53.8K
Volumen promedio
119.9K
EPS (TTM)
-0.51
Rendimiento de dividendos
--
Cap. de mercado
$93.4M
¿Qué es ADAG?
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. The company is headquartered in Suzhou, Jiangsu and currently employs 138 full-time employees. The company went IPO on 2021-02-09. The firm is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved